Publications by authors named "M Haskovic"

Article Synopsis
  • Messenger RNA (mRNA) is being tested as a new treatment for classic galactosemia (CG), a genetic disorder caused by a lack of the GALT enzyme, impacting metabolism and leading to serious health issues.
  • In a zebrafish model of CG, researchers injected human GALT mRNA using lipid nanoparticles, resulting in expression of the GALT protein and improved enzyme activity within just five days post fertilization.
  • The study found that mRNA therapy reduced harmful metabolites in the zebrafish without any noticeable toxicity, suggesting that this model could effectively evaluate future therapies for CG.
View Article and Find Full Text PDF

Nucleotide sugars (NS) are fundamental molecules in life and play a key role in glycosylation reactions and signal conduction. Several pathways are involved in the synthesis of NS. The Leloir pathway, the main pathway for galactose metabolism, is crucial for production of uridine diphosphate (UDP)-glucose and UDP-galactose.

View Article and Find Full Text PDF

Since the first description of galactosemia in 1908 and despite decades of research, the pathophysiology is complex and not yet fully elucidated. Galactosemia is an inborn error of carbohydrate metabolism caused by deficient activity of any of the galactose metabolising enzymes. The current standard of care, a galactose-restricted diet, fails to prevent long-term complications.

View Article and Find Full Text PDF

Background: Classic galactosemia is a rare inborn error of carbohydrate metabolism, caused by a severe deficiency of the enzyme galactose-1-phosphate uridylyltransferase (GALT). A galactose-restricted diet has proven to be very effective to treat the neonatal life-threatening manifestations and has been the cornerstone of treatment for this severe disease. However, burdensome complications occur despite a lifelong diet.

View Article and Find Full Text PDF

Background: GALT deficiency is a rare genetic disorder of carbohydrate metabolism. Due to the decreased activity or absence of the enzyme galactose-1-phosphate uridylyltransferase (GALT), cells from affected individuals are unable to metabolize galactose normally. Lactose consumption in the newborn period could potentially lead to a lethal disease process with multi-organ involvement.

View Article and Find Full Text PDF